Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
17.34
-0.52 (-2.89%)
Sep 3, 2025, 4:00 PM - Market closed
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 6 analysts that cover Elanco Animal Health stock have a consensus rating of "Buy" and an average price target of $17.33, which forecasts a -0.03% decrease in the stock price over the next year. The lowest target is $13 and the highest is $19.
Price Target: $17.33 (-0.03%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $18 | Hold | Maintains | $12 → $18 | +3.84% | Aug 11, 2025 |
| UBS | UBS | Strong Buy Maintains $18 → $19 | Strong Buy | Maintains | $18 → $19 | +9.60% | Aug 8, 2025 |
| UBS | UBS | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +3.84% | Jul 23, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $18 | Hold → Buy | Upgrades | $18 | +3.84% | Jul 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $17 | Strong Buy | Maintains | $16 → $17 | -1.93% | Jul 2, 2025 |
Financial Forecast
Revenue This Year
4.69B
from 4.44B
Increased by 5.65%
Revenue Next Year
4.92B
from 4.69B
Increased by 4.97%
EPS This Year
0.91
from 0.68
Increased by 33.23%
EPS Next Year
1.01
from 0.91
Increased by 11.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.8B | 5.1B | |||
| Avg | 4.7B | 4.9B | |||
| Low | 4.5B | 4.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.2% | 9.4% | |||
| Avg | 5.7% | 5.0% | |||
| Low | 0.5% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.96 | 1.10 | |||
| Avg | 0.91 | 1.01 | |||
| Low | 0.83 | 0.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 40.5% | 21.7% | |||
| Avg | 33.2% | 12.0% | |||
| Low | 22.5% | 2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.